Citations 1
Bevacizumab and improvement of progression-free survival (PFS) for patients with the mesenchymal molecular subtype of ovarian cancer.
Winterhoff, Boris , Kommoss, Stefan , Oberg, Ann L. , Riska, Shaun M., Konecny, Gottfried E. , Fan, Jian‐Bing , Shridhar, Viji , Goode, Ellen L. , Kommoss, Friedrich, Hilpert, Felix , Parmar, Mahesh, Hartmann, Lynn C. , Pfisterer, Jacobus , Dowdy, Sean C. , Parmar, Mahesh , Wang, Chen , Bois, Andreas du , Chien, Jeremy , Embleton-Thirsk, Andrew , Kaplan, Richard , Perren, Timothy
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 5509-5509
